CX Institutional’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $499K | Sell |
2,258
-304
| -12% | -$84.1K | 0.01% | 475 |
|
|
2026
Q1 | $757K | Sell |
2,562
-4
| -0.2% | -$1.19K | 0.02% | 383 |
|
|
2025
Q4 | $701K | Buy |
2,566
+90
| +4% | +$24.5K | 0.02% | 339 |
|
|
2025
Q3 | $669K | Sell |
2,476
-388
| -14% | -$106K | 0.02% | 366 |
|
|
2025
Q2 | $789K | Sell |
2,864
-12
| -0.4% | -$3.26K | 0.03% | 301 |
|
|
2025
Q1 | $763K | Buy |
2,876
+265
| +10% | +$65.4K | 0.03% | 309 |
|
|
2024
Q4 | $606K | Buy |
2,611
+32
| +1% | +$7.36K | 0.02% | 317 |
|
|
2024
Q3 | $569K | Sell |
2,579
-13,060
| -84% | -$2.7M | 0.03% | 353 |
|
|
2024
Q2 | $3.07M | Buy |
15,639
+1,119
| +8% | +$231K | 0.14% | 160 |
|
|
2024
Q1 | $3.13M | Buy |
14,520
+532
| +4% | +$112K | 0.15% | 164 |
|
|
2023
Q4 | $2.95M | Sell |
13,988
-822
| -6% | -$175K | 0.16% | 176 |
|
|
2023
Q3 | $2.97M | Buy |
14,810
+12,664
| +590% | +$2.52M | 0.16% | 165 |
|
|
2023
Q2 | $398K | Buy |
2,146
+292
| +16% | +$54K | 0.02% | 376 |
|
|
2023
Q1 | $354K | Buy |
1,854
+151
| +9% | +$27.3K | 0.02% | 390 |
|
|
2022
Q4 | $286K | Buy |
+1,703
| New | +$296K | 0.02% | 437 |
|
|
2022
Q3 | – | Sell |
-995
| Closed | -$204K | – | 581 |
|
|
2022
Q2 | $204K | Buy |
995
+42
| +4% | +$8.9K | 0.02% | 433 |
|
|
2022
Q1 | $227K | Buy |
+953
| New | +$224K | 0.02% | 343 |
|
|
2021
Q4 | – | Sell |
-693
| Closed | -$134K | – | 430 |
|
|
2021
Q3 | $134K | Sell |
693
-35
| -5% | -$7.09K | 0.01% | 400 |
|
|
2021
Q2 | $155K | Buy |
728
+160
| +28% | +$33.8K | 0.01% | 371 |
|
|
2021
Q1 | $116K | Buy |
568
+103
| +22% | +$20.3K | 0.01% | 362 |
|
|
2020
Q4 | $85K | Buy |
465
+166
| +56% | +$28.2K | 0.01% | 384 |
|
|
2020
Q3 | $50K | Buy |
299
+193
| +182% | +$32.5K | 0.01% | 384 |
|
|
2020
Q2 | $17K | Buy |
106
+50
| +89% | +$8.96K | ﹤0.01% | 472 |
|
|
2020
Q1 | $10K | Sell |
56
-33
| -37% | -$6.57K | ﹤0.01% | 449 |
|
|
2019
Q4 | $18K | Hold |
89
| – | – | ﹤0.01% | 356 |
|
|
2019
Q3 | $19K | Hold |
89
| – | – | ﹤0.01% | 377 |
|
|
2019
Q2 | $17K | Buy |
+89
| New | +$16.4K | ﹤0.01% | 414 |
|
|
2019
Q1 | – | Sell |
-15
| Closed | -$3K | – | 783 |
|
|
2018
Q4 | $3K | Buy |
+15
| New | +$2.77K | ﹤0.01% | 422 |
|
Other funds holding CME
CX Institutional's CME Position: Q2 2026 in Review
CX Institutional reduced its CME Group (CME) stake by 12% in Q2 2026, selling an estimated $84.1K and leaving 2,258 shares worth $499K. The position accounts for 0.01% of the portfolio, ranked #475.
CX Institutional first reported a position in CME in Q4 2018 and has held it in 28 quarters since. The position peaked at $3.13M in Q1 2024. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- CX Institutional held 2,258 shares of CME Group worth $499K as of Q2 2026.
- CX Institutional sold 304 CME Group shares in Q2 2026, an estimated $84.1K.
- CME Group made up 0.01% of CX Institutional's portfolio in Q2 2026, its #475 holding.
- CX Institutional first reported a position in CME Group in Q4 2018 and has held it in 28 quarters since.
- CX Institutional's CME Group position peaked at $3.13M in Q1 2024.
- 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.